Health TrialsbyHealthPanel

Subthreshold Stimulation Versus Suprathreshold Stimulation in People With Chronic Low Neck Pain

ConditionsPainTrigger Point Pain, Myofascial
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorBeni-Suef University

About this trial

this trial will involve three groups. Group 1 will receive subthreshold stimulation. Group 2 will receive suprathreshold stimulation. Group 3 will receive shame treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age from 40 to 65 years old participated in this study, 2

Having neck pain for more than 6 months with a grade five or greater on the visual analog scale

Having one or more trigger points in the upper trapezius muscle,

A significant increase in neck muscle EMG activity indicates the presence of tender points.

Disqualifiers

Taking non-pharmacological therapies (e.g., acupuncture, physical therapy, osteopathy)

Taking oral or intravenous pain therapy, intramuscular or subcutaneous injection of cortisone, or local anesthetics during the study period,

Presence of any contraindication to electrical current including pregnancy, epilepsy, cardiac arrhythmia, cardiac surgery, implanted pacemaker or defibrillator, previous surgery in the spinal cord, infectious diseases of the spinal cord, malignant tumors with or without secondary blastomas in the spinal cord, severe radicular pain with acute paralysis in the extremities

Trial design

Design model

Parallel

Treatments tested in this trial

  • electrical stimulation

    Device

    A two-channel portable electrical stimulation unit (BTL-4620, Czech Republic).

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Group 1Experimental treatment 1 intervention
Group B: Group 2Experimental treatment 1 intervention
Group C: Group 3Sham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain intensity

Neck pain intensity will be assessed by the visual analog scale (VAS). Participants will be asked to explain their present pain by putting a mark on a 10 mm horizontal line with 0 degrees indicating "no pain" and 10 indicating the "worst possible pain"

Time frame
2-3 months
2

Pressure threshold

Myofascial trigger points' sensitivity will be measured by a pressure-pain algometer from upper trapezius muscle.

Time frame
2-3 months
3

Electromyography

The EMG activity from the upper trapezius muscle will be recorded during rest and voluntary maximum contraction.

Time frame
2-3 months
4

Range of motion

Flexion, lateral rotation to both sides, lateral flexion to both sides

Time frame
2-3 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Beni-Suef University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: